Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 7 | 2018 | 935 | 0.770 |
Why?
|
| MicroRNAs | 5 | 2022 | 426 | 0.760 |
Why?
|
| Transcription Factors | 4 | 2018 | 681 | 0.650 |
Why?
|
| Cell Movement | 3 | 2016 | 571 | 0.580 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2022 | 807 | 0.540 |
Why?
|
| Kidney | 3 | 2014 | 337 | 0.420 |
Why?
|
| STAT1 Transcription Factor | 1 | 2010 | 35 | 0.360 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 62 | 0.350 |
Why?
|
| Glycoproteins | 2 | 2011 | 106 | 0.330 |
Why?
|
| Mucin-1 | 2 | 2004 | 9 | 0.290 |
Why?
|
| Cell Proliferation | 6 | 2018 | 1198 | 0.280 |
Why?
|
| Phosphotyrosine | 1 | 2004 | 23 | 0.250 |
Why?
|
| Neoplasm Invasiveness | 3 | 2016 | 251 | 0.240 |
Why?
|
| Antigens | 1 | 2004 | 56 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 136 | 0.230 |
Why?
|
| Tyrosine | 1 | 2003 | 118 | 0.220 |
Why?
|
| Mesoderm | 2 | 2014 | 70 | 0.210 |
Why?
|
| Apoptosis | 4 | 2016 | 1398 | 0.210 |
Why?
|
| Cell Nucleus | 2 | 2014 | 366 | 0.190 |
Why?
|
| Wnt Proteins | 2 | 2011 | 22 | 0.190 |
Why?
|
| STAT3 Transcription Factor | 2 | 2013 | 90 | 0.190 |
Why?
|
| RNA, Messenger | 4 | 2022 | 1207 | 0.170 |
Why?
|
| Kidney Neoplasms | 2 | 2010 | 68 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 623 | 0.160 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 76 | 0.160 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1502 | 0.150 |
Why?
|
| Flow Cytometry | 2 | 2016 | 399 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 515 | 0.140 |
Why?
|
| Humans | 15 | 2022 | 37093 | 0.130 |
Why?
|
| Transcription, Genetic | 2 | 2016 | 578 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2016 | 212 | 0.130 |
Why?
|
| Cell Line, Tumor | 7 | 2018 | 2231 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 502 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2014 | 29 | 0.120 |
Why?
|
| Phosphorylation | 3 | 2013 | 928 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2010 | 194 | 0.120 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 103 | 0.120 |
Why?
|
| Antibodies | 2 | 2004 | 141 | 0.120 |
Why?
|
| Transcriptional Activation | 2 | 2011 | 172 | 0.110 |
Why?
|
| Male | 8 | 2018 | 20025 | 0.110 |
Why?
|
| Telomerase | 1 | 2011 | 44 | 0.100 |
Why?
|
| Antigens, CD | 1 | 2011 | 121 | 0.100 |
Why?
|
| Nuclear Lamina | 1 | 2010 | 1 | 0.090 |
Why?
|
| Progeria | 1 | 2010 | 9 | 0.090 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2010 | 5 | 0.090 |
Why?
|
| Nephrons | 1 | 2011 | 22 | 0.090 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 11 | 0.090 |
Why?
|
| Xenopus laevis | 1 | 2010 | 73 | 0.090 |
Why?
|
| Casein Kinase II | 1 | 2010 | 15 | 0.090 |
Why?
|
| Proline Oxidase | 1 | 2010 | 11 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2014 | 1908 | 0.090 |
Why?
|
| Cell Differentiation | 2 | 2011 | 587 | 0.090 |
Why?
|
| Cell Line | 2 | 2004 | 1354 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 115 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 152 | 0.090 |
Why?
|
| Wilms Tumor | 1 | 2009 | 4 | 0.080 |
Why?
|
| RNA Interference | 1 | 2010 | 243 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 2010 | 250 | 0.080 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 49 | 0.080 |
Why?
|
| Peptides | 1 | 2011 | 320 | 0.080 |
Why?
|
| Ubiquitin | 1 | 2008 | 78 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2011 | 444 | 0.080 |
Why?
|
| Models, Biological | 1 | 2011 | 677 | 0.070 |
Why?
|
| Aged | 3 | 2014 | 6741 | 0.070 |
Why?
|
| Animals | 7 | 2018 | 15081 | 0.070 |
Why?
|
| Epidermal Growth Factor | 2 | 2018 | 68 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 2379 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 628 | 0.060 |
Why?
|
| Neoplasm Transplantation | 2 | 2018 | 122 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 219 | 0.060 |
Why?
|
| Mucins | 1 | 2004 | 35 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 803 | 0.060 |
Why?
|
| Middle Aged | 3 | 2014 | 10129 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2004 | 59 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2014 | 626 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 188 | 0.060 |
Why?
|
| Cadherins | 2 | 2014 | 90 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 169 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 295 | 0.050 |
Why?
|
| Protein Transport | 2 | 2014 | 302 | 0.050 |
Why?
|
| Mice | 4 | 2018 | 5913 | 0.050 |
Why?
|
| Young Adult | 1 | 2012 | 4268 | 0.050 |
Why?
|
| Proteomics | 1 | 2022 | 325 | 0.050 |
Why?
|
| Gene Expression | 2 | 2014 | 674 | 0.050 |
Why?
|
| Adult | 2 | 2014 | 11712 | 0.040 |
Why?
|
| Neoplasms | 1 | 2008 | 1103 | 0.040 |
Why?
|
| Quinazolines | 1 | 2018 | 33 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2010 | 859 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2018 | 151 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2018 | 337 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2011 | 1518 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2018 | 325 | 0.030 |
Why?
|
| Molecular Biology | 1 | 2014 | 46 | 0.030 |
Why?
|
| Female | 3 | 2022 | 20969 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2012 | 65 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 77 | 0.030 |
Why?
|
| Rats | 2 | 2011 | 3483 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 173 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 2011 | 15 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 408 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 91 | 0.020 |
Why?
|
| Chromatin | 1 | 2013 | 169 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 150 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 93 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 689 | 0.020 |
Why?
|
| Ionomycin | 1 | 2011 | 10 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2011 | 15 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2011 | 17 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2011 | 50 | 0.020 |
Why?
|
| Proteins | 1 | 2014 | 369 | 0.020 |
Why?
|
| Lamin Type A | 1 | 2010 | 13 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 78 | 0.020 |
Why?
|
| beta Catenin | 1 | 2011 | 48 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 74 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2011 | 33 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 136 | 0.020 |
Why?
|
| Luciferases | 1 | 2010 | 63 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 409 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2010 | 74 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2010 | 153 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2011 | 101 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 601 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 306 | 0.020 |
Why?
|
| Ethylnitrosourea | 1 | 2009 | 2 | 0.020 |
Why?
|
| WT1 Proteins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Breeding | 1 | 2009 | 21 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 2009 | 13 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2009 | 133 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 448 | 0.020 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2008 | 18 | 0.020 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2008 | 16 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 286 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 272 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 435 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 997 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 114 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 933 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 213 | 0.020 |
Why?
|
| Mutation | 1 | 2009 | 1095 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1618 | 0.010 |
Why?
|